Transcranial Magnetic Stimulation pilot

The GMHBA TMS Pilot will end 1 November 2021.

In 2018 GMHBA engaged TMS Clinics Australia (TMSA) to provide outpatient TMS as a hospital substitution program to eligible members. This was a 2 year pilot, that was then extended an additional year, ending 1 November 2021.

On review of the pilot, GMHBA has decided not to extend the program. While GMHBA will no longer be paying benefits towards outpatient TMS services, if you require further treatment we recommend speaking to your treating physician or doctor.

What is TMS?

TMSA was founded by psychiatrists Professor Paul Fitzgerald and Dr Ted Cassidy, who both have extensive experience treating patients for depression using TMS. This treatment is based on the latest research to ensure you receive the most up to date protocols with the best possible treatment outcomes.

The aims of this service are to alleviate severe or treatment resistant Major Depressive Disorder (MDD) to allow patients to return to a greater degree of functioning, and to reduce the requirement for inpatient treatment for participating members which is disruptive to psychosocial rehabilitation.
If you are eligible for the program, TMSA will work collaboratively with your treating psychiatrist (with your permission) and request any clinical information that may be of assistance in developing your TMS treatment plan.

Further information about TMS Clinics Australia can be found on the TMS Clinic Australia website.